It was 1994, and geneticist Mary E. Brunkow, who this week became a newly minted Nobel laureate, had just started at Darwin Molecular after completing postdoctoral research. The world of genetic ...
IRF5 program strengthens Kymera’s oral immunology pipeline with a complementary mechanism to expand into rheumatic and other autoimmune diseases with a potential best-in-class oral drug IRF5, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback